RWJ 22108

an antiasthmatic agent; structure given in first source

Also Known As:

N-benzyl-N-methylaminoethyl-9-(2-chloro-6-fluorophenyl)-2,3,4,5,6,9-hexahydro-7-methyl-1,1-dioxothiacyclohepteno-(3,2-b)pyridine-8-carboxylate; RWJ-22108

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - RWJ 22108: 1

Related Diseases

1.	Asthma (Bronchial Asthma) 01/01/1993 - "These data suggest that RWJ 22108 may have pharmacological potential in the clinical management of asthma." 01/01/1993 - "The current study demonstrates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. " 01/01/1993 - "In a conscious sheep model of allergic asthma, aerosol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. "
2.	Airway Obstruction (Choking) 01/01/1993 - "The current study demonstrates the in vivo activity of RWJ 22108 in several different models of airway obstruction and asthma. " 01/01/1993 - "In a conscious sheep model of allergic asthma, aerosol RWJ 22108 inhibits antigen-induced early and late phase airway obstruction and also the cellular infiltration associated with late phase. "

Related Drugs and Biologics

1.	Antigens
2.	Aerosols